SCHEMBL12192882

SCHEMBL12192882

Cc1cc(OC2CCNCC2)c(C)c2ccncc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKB O14920 8/20 0.50
▸ CHUK O15111 7/20 0.50
▸ ROCK1 Q13464 5/20 0.46
▸ LCK P06239 2/20 0.46
▸ MKNK1 Q9BUB5 1/20 0.41
▸ MKNK2 Q9HBH9 1/20 0.41
▸ AKT1 P31749 1/20 0.41
▸ ACVR1B P36896 1/20 0.41
▸ TGFBR1 P36897 1/20 0.41
▸ ACVR1 Q04771 1/20 0.41
▸ KCNH2 Q12809 1/20 0.41
▸ ROCK2 O75116 2/20 0.40
▸ CDC42BPB Q9Y5S2 2/20 0.40
▸ PRKCZ Q05513 1/20 0.40
▸ PIM1 P11309 1/20 0.40
▸ MELK Q14680 1/20 0.39
▸ CHRNB2 P17787 1/20 0.38
▸ CHRNA4 P43681 1/20 0.38
▸ CDC42BPA Q5VT25 1/20 0.38
▸ HRH1 P35367 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12192883 0.84 IKBKB (0.62) IKBKBCHUKROCK1LCKMKNK1
SCHEMBL12192613 0.80 IKBKB (0.54) IKBKBCHUKROCK1LCKMKNK1
Hydrochloric Acid SCHEMBL2497632 0.79 IKBKB (0.53) IKBKBCHUKROCK1LCKMKNK1
SCHEMBL23021685 0.79 IKBKB (0.55) IKBKBCHUKROCK1LCKMKNK1
SCHEMBL8271735 0.79 IKBKB (0.55) IKBKBCHUKROCK1LCKMKNK1
Hydrochloric Acid SCHEMBL70622 0.77 IKBKB (0.53) IKBKBCHUKROCK1LCKMKNK1
Hydrochloric Acid SCHEMBL4120289 0.77 IKBKB (0.53) IKBKBCHUKROCK1LCKMKNK1
SCHEMBL12192879 0.76 IKBKB (0.64) IKBKBCHUKROCK1LCKAKT1
SCHEMBL12193216 0.75 IKBKB (0.72) IKBKBCHUKROCK1LCKMKNK1
SCHEMBL14239774 0.74 IKBKB (0.50) IKBKBCHUKROCK1LCKMKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722671-B2 Isoquinoline derivatives SANOFI (FR) 2014-05-13 — — US disclosed
US-8722671-B2 Isoquinoline derivatives SANOFI (FR) 2014-05-13 — — US disclosed
US-8501736-B2 Isoquinoline derivatives SANOFI (FR) 2013-08-06 — — US disclosed
US-8501736-B2 Isoquinoline derivatives SANOFI (FR) 2013-08-06 — — US disclosed
US-20110245248-A1 ISOQUINOLINE DERIVATIVES SANOFI-AVENTIS (FR) 2011-10-06 — — US disclosed
US-20110245248-A1 ISOQUINOLINE DERIVATIVES SANOFI-AVENTIS (FR) 2011-10-06 — — US disclosed
EP-1899322-B1 ISOQUINOLINE DERIVATIVES AS INHIBITORS OF RHO-KINASE SANOFI AVENTIS (FR) 2009-09-02 — — EP disclosed
US-20090088429-A1 Isoquinoline Derivatives SANOFI-AVENTIS (FR) 2009-04-02 — — US disclosed
US-20090088429-A1 Isoquinoline Derivatives SANOFI-AVENTIS (FR) 2009-04-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245248-A1 ISOQUINOLINE DERIVATIVES MYLK2, MYLK, RHOT2 IKBKB 866/4885CHUK 955/4885ROCK1 7/4885
US-20090088429-A1 Isoquinoline Derivatives MYLK2, MYLK, RHOT2 IKBKB 866/4885CHUK 955/4885ROCK1 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback